812.65 -13.50 (-1.63%)

46.00% Fall from 52W High

1.0M NSE+BSE Volume

High volume today

NSE 14 Nov, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Margin Decline
Natco Pharma's Q2 net profit drops 23.5% YoY, EBITDA margin plunges 14 percentage points to 46.4% See details


Natco Pharma Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for NATCOPHARM, BSE:524816 Natco Pharma Ltd.

589 Votes:
Buy 82.85%
Sell 7.47%
Hold 9.68%
BUY
SELL
HOLD